Beijing CorreGene Biotechnology Co., Ltd., founded by several Peking University alumni, dedicated to the development of innovative therapeutics based on T-cell receptors (TCRs).
CorreGene has established a comprehensive research and development platform for T cell receptor (TCR) technology, incorporating breakthroughs in TCR cloning and affinity optimization. Inparticular, the proprietary SMART-TCR affinity optimization platform, a revolutionarytechnology in TCR affinity optimization, has significantly increased thesuccess rate and efficiency of TCR optimization. This groundbreaking platformhas effectively overcome previous barriers in the development of TCR-basedmedications.
Currently, CorreGene is developing multiple First-in-class TCR-T cell therapies and TCR bispecifics, including the pioneering cell therapy drug targeting the KRAS-G12 mutations in China and world-first TCR bispecific targeting HPV infectious diseases, aiming to building a global leader in TCR-based immunotherapies.
In the future, CorreGene will pioneering distinct therapeutic modalities of T cell receptors (TCRs) for ACT and Bispecifics for tumor, chronic infection and autoimmune disease, aiming to the trillion-level markets.
Company Details
- Employees
- 27
- Founded
- -
- Address
- 3rd Floor, North Building, Changfazhan International Precision Medicine Acceleration Center , No. 21 Shengmingyuan West Road, Changping District, Beijing, 304,china
- Industry
- Biotechnology Research
- NAICS
-
Research and Development in Biotechnology (except Nanobiotechnology)
- Website
- http://www.corregene.com/
- Keywords
- TCR-T Cell Therapy, TCR Bispecific Antibody Drugs, KRAS G12V/D, TCR Affinity Optimization, Solid tumor, Cell Therapy, HPV, MAGEA1.
- HQ
- Beijing, Beijing
Corregene Biotechnology Questions
Corregene Biotechnology's website is http://www.corregene.com/
Corregene Biotechnology's LinkedIn profile is https://cn.linkedin.com/company/corregene-biotechnology-co-ltd
Corregene Biotechnology has
27 employees.
View email and phone details for 27
employees at Corregene Biotechnology.
Corregene Biotechnology's industry is
Biotechnology Research
Corregene Biotechnology's top competitors are
Danausgt,
Gradiant Bioconvergence,
Wuxi Extpure Solutions Co., Ltd,
Icardiooncology 三度医学,
Genassist Ltd,
Seekin Inc,
Linkgpt,
Bc Marketing Consulting,
四川百利药业有限公司,
红日药业.
Corregene Biotechnology's categories are Biotechnology Research
Corregene Biotechnology's founding year is 2016
